Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Google Preparing Language Teaching Via Search

https://www.theinformation.com/

byBenzinga Newsdesk

June 16, 2021

1 minute read

https://www.theinformation.com/

Honeywell To $194? Plus Citigroup Slashes PT On This Stock By Over 93%

By Lisa Levin

Today, 10:57 PM

Daiwa Capital slashed the price target on Honeywell International Inc. (NYSE: HON) from $206 to $194. Honeywell shares fell 0.6% to $203.79 in pre-market trading.

CHTR

News

Triumph Says Selected To Support Boeing Vertical Lift Sustainment Depot Repair Program

By Benzinga Newsdesk

Today, 10:57 PM

Triumph Group (NYSE:TGI) announced that it has signed a repair and overhaul services agreement with Boeing for engine driven pumps on the AH-64 Apache. The long-term agreement supports the Boeing Vertical Lift

TGI

UPDATE: Tronox Is Another Rare Earth Play; Stock Was Quiet Amid Report Pentagon Will Raise Its Stockpile Of Rare Earth Minerals, Lithium

By Benzinga Newsdesk

Today, 10:57 PM

-Reuters

TROX

Seagen Reports Data From SEA-CD40 In Combination With Other Therapies In Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) At American Society of Clinical Oncology Gastrointestinal Cancers Symposium

By Benzinga Newsdesk

Today, 10:57 PM

Seagen Inc. (NASDAQ:SGEN) today announced data from a phase 1 clinical trial combining SEA-CD40 with chemotherapy and an anti-PD-1 in patients with metastatic PDAC at the ASCO GI annual meeting taking place in San

SGEN

Google Preparing Language Teaching Via Search

Related Posts

Honeywell To $194? Plus Citigroup Slashes PT On This Stock By Over 93%

Triumph Says Selected To Support Boeing Vertical Lift Sustainment Depot Repair Program

UPDATE: Tronox Is Another Rare Earth Play; Stock Was Quiet Amid Report Pentagon Will Raise Its Stockpile Of Rare Earth Minerals, Lithium

Seagen Reports Data From SEA-CD40 In Combination With Other Therapies In Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) At American Society of Clinical Oncology Gastrointestinal Cancers Symposium